The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes
in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung …

CFRD remains one of the most important co-morbidities in CF. Early recognition of the
disease and therapeutic intervention may diminish the negative impact that diabetes has on …

Cystic fibrosis related diabetes (CFRD) is the most common co‐morbidity in persons with
cystic fibrosis (CF). As the life expectancy of persons with CF continues to increase, the need …

Cystic fibrosis–related diabetes (CFRD) is among the most common extrapulmonary co-
morbidity associated with cystic fibrosis (CF), affecting an estimated 50% of adults with the …

Cystic fibrosis‐related diabetes (CFRD) is associated with both an increase in morbidity and
mortality in people with cystic fibrosis (CF). With increased screening and improved life …

Data derived from a cross‐sectional analysis of 7,566 patients stratified into six age groups
were used to compare lung function, body mass index (BMI), and weight for age in patients …

Cystic fibrosis-related diabetes (CFRD) is a frequent complication of cystic fibrosis, its
prevalence increases with age of patient and is close to 30% at the age of 30 years. As life …

Cystic fibrosis-related diabetes (CFRD) is a common complication of CF that increases in
incidence as patients age. Poor glycemic control has been shown to negatively impact lung …

Individuals with cystic fibrosis and pancreatic insufficiency have a gradual decline in insulin
secretion over time, which results in an increase in the prevalence of diabetes with age; up …

Improved life expectancy in cystic fibrosis (CF) has led to an expanding population of adults
with CF, now representing almost 50% of the total CF population. This creates new …